Showing results (121-130 of 777) with videos related to
Sort By:
Pageof 78
Journal of the National Comprehensive Cancer Network : JNCCN|November 3, 2009
Novel therapies in the treatment of multiple myelomaJacob P Laubach, Constantine S Mitsiades, Anuj Mahindra, et al.International Journal of Oncology|February 1, 2014
IKKβ inhibitor in combination with bortezomib induces cytotoxicity in breast cancer cellsHiromasa Hideshima, Yasuhiro Yoshida, Hiroshi Ikeda, et al.Expert Opinion on Emerging Drugs|March 3, 2009
Emerging therapies for multiple myelomaKlaus Podar, Yu-Tzu Tai, Teru Hideshima, et al.Blood|June 21, 2003
NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myelomaLaurence Catley, Ellen Weisberg, Yu-Tzu Tai, et al.British Journal of Haematology|July 19, 2006
Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomibReshma Shringarpure, Laurence Catley, Deepak Bhole, et al.The Journal of Biological Chemistry|December 17, 2002
Essential role of caveolae in interleukin-6- and insulin-like growth factor I-triggered Akt-1-mediated survival of multiple myeloma cellsKlaus Podar, Yu-Tzu Tai, Craig E Cole, et al.Blood|December 3, 2003
GW654652, the pan-inhibitor of VEGF receptors, blocks the growth and migration of multiple myeloma cells in the bone marrow microenvironmentKlaus Podar, Laurence P Catley, Yu-Tzu Tai, et al.Current Pharmaceutical Design|September 29, 2012
New insights into the treatment of multiple myeloma with histone deacetylase inhibitorsMichele Cea, Antonia Cagnetta, Marco Gobbi, et al.Cancer Research|April 17, 2004
Mechanisms by which SGN-40, a humanized anti-CD40 antibody, induces cytotoxicity in human multiple myeloma cells: clinical implicationsYu-Tzu Tai, Laurence P Catley, Constantine S Mitsiades, et al.Blood|September 13, 2003
Identification of genes modulated in multiple myeloma using genetically identical twin samplesNikhil C Munshi, Teru Hideshima, Daniel Carrasco, et al.Pageof 78